Small Business Resources, Business Advice and Forms from AllBusiness.com
See All Periodicals
Business Periodicals

HIV Treatment: ALERTS!

Search for a specific term, browse the articles listed below, or view the archives at the bottom of the page.

Search HIV Treatment: ALERTS! for:

Issue Date: 04/01/2005

Periodical Article Results

1-10 (of 54) related articles Items per page
1. Studies in Galveston.
SCH 417690 (vicraviroc) is a new HIV medication that is under investigation and not yet approved by the Food and Drug Administration (FDA). It is ...
(PERIODICAL ARTICLE)
2. SMART Study.
The SMART Study continues enrollment in Houston and around the world. SMART stands for Strategies for the Management of Anti-Retroviral Therapy. The study will involve ...
(PERIODICAL ARTICLE)
3. Baylor College of Medicine.
Cytomegalovirus (CMV) is a very common virus that infects many HIV-negative and HIV+ people in the US. CMV can infect many different parts of the ...
(PERIODICAL ARTICLE)
4. The immune system (Part 1 of 2): T cells, B cells, and cytokines.
The immune system is a complex system whose main job is to protect the body from foreign invaders like bacteria or viruses. The immune system ...
(PERIODICAL ARTICLE)
5. Useful resources.
* Want more coverage of the Retrovirus Conference? Find abstracts, posters, and even recorded presentations at www.retroconference.org * Search HIV/AIDS clinical trials by topic, state, ...
(PERIODICAL ARTICLE)
6. Is an undetectable viral load necessary?
Achieving an undetectable viral load is not always possible. Instead, some patients stay at a detectable, but moderate, level for years. This is sometimes called ...
(PERIODICAL ARTICLE)
7. STD dangers.
Syphilis, a sexually transmitted disease (STD), is caused by a type of bacteria and is spread through direct contact with a syphilis sore (also called ...
(PERIODICAL ARTICLE)
8. First hepatitis C treatment approved for co-infected patients.
In February 2005, the FDA approved the combination of Pegasys (peg-Interferon) and Copegus (ribavirin) for the treatment of hepatitis C virus (HCV) in HIV+ patients.
(PERIODICAL ARTICLE)
9. Liver toxicity warning.
Patients taking either boosted or unboosted Invirase (saquinavir, hard gel capsules) or Fortavase (saquinavir, soft-gel capsules) should not take rifampin (brand names include Rifadin and ...
(PERIODICAL ARTICLE)
10. Pregnant women should not use Crixivan.
The protease inhibitor Crixivan should not be used in HIV+ pregnant women. New data have shown that blood levels of Crixivan are lower in pregnant ...
(PERIODICAL ARTICLE)
1-10 (of 54) related articles Items per page

123456Next

white_tab_grey_lft  - newer  
white_tab_grn_lft 2007 white_tab_grey_lft 2005 white_tab_grey_lft 2004 white_tab_grey_lft 2003 white_tab_grey_lft 2002 white_tab_grey_lft 2001 white_tab_grey_lft older -   
white_tab_grn_lft